Search results
When will Novavax's vaccine be available, and how can I get it?
CBS News via Yahoo News· 2 years agoThe Biden administration is warning states to prepare for a "limited supply" of Novavax's COVID-19...
What’s in the Novavax Vaccine? Experts Break It All Down
Prevention via Yahoo News· 2 years agoThe Food and Drug Administration has authorized Novavax’s COVID-19 vaccine for use in the U.S....
FDA authorizes Novavax as new alternative to mRNA COVID-19 vaccines
CBS News via Yahoo News· 2 years agoThe Food and Drug Administration has granted Novavax's COVID-19 vaccine emergency use authorization,...
Novavax hopes FDA go-ahead will boost lagging US vaccinations
The Hill via Yahoo News· 2 years agoFederal regulators appear poised to finally authorize a COVID-19 vaccine from Novavax in the coming...
Novavax COVID shot, aimed at vaccine skeptics, overwhelmingly backed by FDA panel
Reuters via Yahoo News· 2 years ago(Reuters) -Advisers to the U.S. Food and Drug Administration on Tuesday voted overwhelmingly to...
Novavax (NVAX) Q1 Earnings Lag, Stock Up 28% on Upbeat '23 View
Zacks via Yahoo Finance· 12 months agoNovavax (NVAX) reports dismal Q1 earnings results, as earnings and revenues miss estimates. However,...
Novavax COVID vaccine, new 4th option, approved by FDA
NY Daily News via AOL· 2 years agoAmericans will soon have a fourth COVID vaccine option. Novavax’s more traditional vaccine was...
Novavax to pause RSV vaccine trial, assess pipeline
Yahoo Finance via AOL· 1 year agoNovavax (NVAX) is facing serious headwinds going into 2023 with the pandemic demand waning and new leadership changes, even as it celebrates a historic...
Novavax Jumps After Pledging To Update Its Covid Shot; Pfizer, Moderna Slip
Investor's Business Daily· 1 year agoNovavax plans to update its Covid shot for new variants, and NVAX stock outperformed its vaccine...
3 Reasons to Buy Novavax and 1 to Sell
Motley Fool· 2 years agoNovavax (NASDAQ: NVAX) is a pandemic stock. Now it's down to $50, and the company's market cap is under $4 billion. Here are three arguments for buying...